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Abstract
Hydrogels are of significant interest for cell encapsulation and delivery in regenerative medicine.
Poly(ester amide)s (PEAs) are a class of biodegradable polymers that exhibit promise for
biomedical applications due to the degradability of the ester and amide linkages in their
backbones, their preparation from biomolecules such as amino acids, and the ability to readily
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tune their properties through a modular synthesis approach. Water-soluble PEAs containing
cationic arginine moieties have previously been developed, but to the best of our knowledge,
neutral water-soluble PEAs based on non-charged amino acids have not been reported. Using a
poly(ethylene glycol) (PEG)-based macromonomer, we described here the syntheses of watersoluble amino acid-containing PEAs containing crosslinkable alkenes in their backbones. These
PEAs were converted into hydrogels through photoinitiated crosslinking and their properties
were compared, including gel content, water content, swelling, and Young’s moduli. Subsequent
cell culture studies on a subset of hydrogels confirmed that human adipose-derived stromal cells
(ASCs) showed >75% viability at 24 hours post-encapsulation. To explore the potential of the
hydrogels as cell delivery systems for applications in soft tissue regeneration, adipogenic
differentiation of the encapsulated ASCs was probed in vitro at 7 days. Analysis of glycerol-3phosphate dehydrogenase (GPDH) enzyme activity and intracellular lipid accumulation indicated
that the hydrogels provided a supportive environment for ASC adipogenesis. Overall, these PEAs
provide a new platform that warrants further development for regenerative medicine applications.
Keywords
Poly(ester amide), hydrogel, regenerative medicine, adipose-derived stromal cell

Introduction
Hydrogels are commonly used as scaffolds for cell delivery and tissue engineering due to their
high water content resembling that of soft tissues and high permeability to oxygen, nutrients and
metabolites [1-3]. Biopolymers such as collagen [4], alginate [5], chitosan [6], hyaluronic acid
(HA) [7] and chondroitin sulfate [8] have been extensively investigated for the preparation of
hydrogels. These materials can be degraded enzymatically, and can have favorable biological
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properties, as they are found naturally within or mimic components of the native extracellular
matrix (ECM) within human tissues. However, challenges for natural materials include batch-tobatch reproducibility in their isolation and processing, as well as limitations in the extent to
which one can tune their chemical and mechanical properties [9]. On the other hand, synthetic
materials can offer a high degree of chemical and mechanical tunability. Polymers including
poly(ethylene glycol) (PEG) [10, 11], poly(lactic acid) [11, 12], and poly(N-isopropylacrylamide)
[13] have been widely explored in hydrogel scaffolds for cell culture and delivery, but without
functionalization these polymers lack the innate biological cues offered by biopolymers.
Poly(ester amide)s (PEAs) are a class of polymers containing ester and amide linkages in
their backbones, which offer advantages of both polyesters and polyamides, including the
biodegradability of polyesters and high mechanical strength and thermal stability of polyamides
[14, 15]. In particular, PEAs derived from amino acids, diols, and dicarboxylic acids have been
investigated for biomedical applications as they offer advantageous aspects of both natural and
synthetic polymers. The incorporated amino acids can be recognized by biological systems and
their enzymatic biodegradation leads to metabolically-degradable building blocks, while their
properties can be readily tuned by varying their monomer components [16-18]. Most of the
incorporated amino acids, diols, and dicarboxylic acids are hydrophobic and the backbone esters
and amides do not impart water-solubility. Consequently, a vast majority of the investigated
amino-acid containing PEAs have been insoluble in aqueous solution and were processed to form
particles [19-21], coatings [22-26], or porous scaffolds by electrospinning [27-30] or particulate
leaching methods [31-33]. However, water-insoluble PEAs cannot be used to prepare hydrogels
capable of encapsulating cells during the gelation process.
Thus far, only a few examples of water-soluble PEAs have been reported. We reported
PEA-PEG graft copolymers that self-assembled into micelles with PEA cores and PEG coronas
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for drug delivery applications [34-36]. However, this structural design did not allow for
crosslinking to form hydrogel networks, as required for cell delivery applications. Chu and
coworkers developed cationic water-soluble PEAs based on L-arginine (Arg) [37] and by
introducing crosslinkable fumaramide moieties into their backbone, they were able to incorporate
these PEAs into hydrogels with poloxamer-diacrylate [38], methacrylate-functionalized HA [39],
glycidyl methacrylate chitosan [40], and gelatin [41]. Alternatively, pendent allyl groups could
also be incorporated as crosslinkers [42]. While cationic Arg moieties are effective in solubilizing
PEAs in water, and can lead to favorable cell attachment in some cases [38], cationic polymers
can be toxic at high concentrations [43] and Arg in particular can interact with phospholipids
through bidentate hydrogen bonding and electrostatics, potentially leading to membrane
disruption or pore formation [44]. To the best of our knowledge, neutral water-soluble PEAs have
not yet been reported.
Here, we report the development of the first non-charged water-soluble PEAs with
crosslinkable moieties to enable hydrogel formation and cell encapsulation. Water solubility was
achieved by the incorporation of a PEG-based macromonomer into the PEA backbone, while
crosslinking capabilities were introduced using fumaramides. The amino acid and diol
components were varied. Properties including gel content, water content, swelling, and Young’s
moduli of the hydrogels fabricated from the different PEAs, and those prepared from the PEAs
with PEG or chondroitin sulfate crosslinkers were studied. Subsequently in vitro culture studies
were performed to investigate the potential of the PEA hydrogels as a cell encapsulation
platform. Human adipose-derived stromal cells (ASCs) were used in these studies, as they
represent an abundant and readily-accessible pro-regenerative cell source [45]. In particular, the
delivery of ASCs within hydrogels has shown promise in adipose tissue engineering strategies
seeking to restore defects caused by trauma, disease or aging [46, 47]. As such, human ASCs
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were encapsulated into the hydrogels through UV crosslinking and their viability and density
were assessed at 24 hr post-encapsulation and at 7 days following the induction of adipogenic
differentiation in culture. In addition, analysis of glycerol-3-phosphate dehydrogenase (GPDH)
activity, a key enzyme involved in lipid biosynthesis, and intracellular lipid accumulation were
performed to determine whether the adipogenic differentiation of the encapsulated ASCs was
impacted by the composition of the PEAs.

Materials and Methods
General Materials. Monomers 1a (L-phenylalanine-1,4-butanediol diester) [48], 1b (Lphenylalanine-1,8-octanediol diester) [48], 1c (L-alanine-1,8-octanediol diester) [49] and 3 (di-pnitrophenyl fumarate) [48] were synthesized as previously reported. Macromonomer 2 (diamino
PEG, 2000 g/mol) and PEG-dimethacrylate (PEG-DMA, 2000 g/mol) were synthesized as
described in the supporting information (Schemes S1-S2). Methacrylated chondroitin sulfate
(MCS) with 17% methacrylation was prepared as previously reported [50]. PEG diol (2000
g/mol) was purchased from Alfa Aesar (Haverhill, MA, USA). 4-Dimethylaminopyridine
(DMAP) and p-toluenesulfonyl chloride were purchased from AK Scientific Inc. (Union City,
CA, USA). Chondroitin sulfate (50,000 g/mol) was purchased from LKT Laboratories (St. Paul,
MN, USA). Toluene, NH4OH, MgSO4, Et3N, CH2Cl2, and N,N-dimethylacetamide (DMA) were
purchased from Caledon Laboratories Inc. (Georgetown, Canada). All other chemicals were
purchased from Sigma Aldrich (St. Louis, MO, USA). All chemicals were used as received
unless otherwise noted. Under a nitrogen atmosphere, toluene was distilled over sodium, while
Et3N, CH2Cl2, and DMA were distilled over CaH2.
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General procedures. Dialysis was performed using Spectra/Por 6 dialysis tubing from Spectrum
Laboratories (Rancho Dominguez, CA, USA) with molecular weight cutoff (MWCO) of 10
kg/mol. 1H nuclear magnetic resonance (NMR) spectra were recorded on either a 400 HMz
Bruker AvIII HD instrument or a 600 MHz Varian INOVA instrument (Figures S1-S7).
Chemical shifts (d) are reported in parts per million with the residual protonated solvent signals
of CDCl3 (d 7.26), D2O (d 4.80) or DMSO-d6 (2.50) as references. Fourier-transform infrared
(FT-IR) spectra were obtained using a Perkin Elmer FT-IR Spectrum Two instrument in
attenuated total reflectance (ATR) mode (Figure S8). Size exclusion chromatography (SEC) was
performed using an instrument equipped with a Waters 515 HPLC pump, a Waters In-Line
Degasser AF, two PLgel mixed D 5µm (300 x 1.5 mm) columns connected to a corresponding
PLgel guard column, and a Wyatt Optilab Rex RI detector operating at 658 nm (Figure S9).
Samples were dissolved in DMF containing 10 mM LiBr and 1% v/v Et3N at a concentration of
~5 mg/mL. Samples were filtered through 0.22 µm polytetrafluoroethylene (PTFE) syringe
filters, and then injected using a 50 µL loop. Samples were run at a flow rate of 1 mL/min for 30
min at 85 °C. The number average molar mass (Mn), weight average molar mass (Mw), and
dispersity (Đ) were determined relative to poly(methyl methacrylate) (PMMA) standards.

Synthesis of Phe-PEA. Monomer 1a (0.30 g, 0.42 mmol, 0.30 equiv.), macromonomer 2 (2.0 g,
0.98 mmol, 0.70 equiv.), and monomer 3 (0.50 g, 1.4 mmol, 1.0 equiv.) were dissolved with
stirring in dry DMA (8.0 mL) at 60 °C. Et3N (0.43 mL, 3.1 mmol, 2.2 equiv.) was added
dropwise to the solution, and then it was stirred at 70 °C for 6 hr. The resulting solution was
concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (250 mL). The crude
product was purified by dialysis against DMF (500 mL) for 48 hr. The solution was then
6

concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (250 mL). The product
was centrifuged, the liquid decanted, and then the solid was dried in vacuo to yield a white solid.
Yield: 70%. 1H NMR (400 MHz, DMSO-d6): δ 8.92-8.87 (m, 0.69H), 8.50-8.46 (m, 1.64H),
7.30-7.19 (m, 4.29H), 6.86-6.83 (m, 2.00H), 4.58-4.52 (m, 0.78H), 3.98 (s, 1.44H), 3.70-3.66 (m,
1.46H), 3.51 (s, 190H) 3.07-2.89 (m, 2.92H) 1.45 (s, 1.48H). FT-IR: 3510, 3295, 2880, 1740,
1640, 1550 cm-1. SEC: Mn = 19.9 kg/mol, Mw = 49.2 kg/mol, Đ = 2.46.

Synthesis of Phe-8-PEA. Monomer 1b (0.066 g, 0.084 mmol, 0.30 equiv.), macromonomer 2
(0.40 g, 0.19 mmol, 0.70 equiv.), and monomer 3 (0.10 g, 0.28 mmol, 1.0 equiv.) were dissolved
with stirring in dry DMA (2.0 mL) at 60 °C. Et3N (0.10 mL, 0.61 mmol, 2.2 equiv.) was added
dropwise to the solution, and then it was stirred at 70 °C for 6 hr. The resulting solution was
concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (100 mL). The crude
product was purified by dialysis against DMF (200 mL) for 48 hr. The solution was then
concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (100 mL). The product
was centrifuged, the liquid decanted, and then the solid was dried in vacuo to yield a white solid.
Yield: 58%. 1H NMR (400 MHz, DMSO-d6): δ 8.89-8.85 (m, 0.69H), 8.50-8.45 (m, 1.58H),
7.29-7.18 (m, 4.23H), 6.85-6.82 (m, 2.00H), 4.56-4.51 (m, 0.66H), 4.00-3.97 (m, 1.36H), 3.693.67 (m, 1.25H), 3.51 (s, 187H), 3.07-2.89 (m, 2.70H), 1.46 (s, 1.49H), 1.19 (s, 3.61H). FT-IR:
3520, 3300, 2880, 1730, 1630, 1550 cm-1. SEC: Mn = 20.1 kg/mol, Mw = 56.6 kg/mol, Đ = 2.81.

Synthesis of Ala-PEA. Monomer 1c (0.26 g, 0.42 mmol, 0.30 equiv.), macromonomer 2 (2.0 g,
0.98 mmol, 0.70 equiv.), and monomer 3 (0.50 g, 1.4 mmol, 1.0 equiv.) were dissolved with
stirring in dry DMA (8.0 mL) at 60 °C. Et3N (0.43 mL, 3.1 mmol, 2.2 equiv.) was added
7

dropwise to the solution, and then it was stirred at 70 °C for 6 hr. The resulting solution was
concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (250 mL). The crude
product was purified by dialysis against DMF (500 mL) for 48 hr. The solution was then
concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (250 mL). The product
was centrifuged, the liquid decanted, and then the solid was dried in vacuo to yield a white solid.
Yield: 77%. 1H NMR (400 MHz, DMSO-d6): δ 8.82-8.78 (m, 0.59H), 8.51-8.45 (m, 1.46H),
6.89-6.83 (m, 2.00H), 4.34-4.29 (m, 0.64H), 4.08-3.97 (m, 1.41H), 3.71-3.65 (m, 1.98H), 3.51 (s,
177H), 1.54 (s, 1.41H), 1.31-1.22 (m, 5.12H). FT-IR: 3521, 3296, 2880, 1737, 1639, 1546 cm-1.
SEC: Mn = 18.9 kg/mol, Mw = 56.1 kg/mol, Đ = 2.96.

Fabrication of hydrogels. Pure (Phe-PEA or Ala-PEA alone) and hybrid (Phe-PEA/Ala-PEA +
PEG-DMA/MCS) hydrogels were fabricated without ASCs for physical characterization studies.
All hydrogels were made with a polymer solution concentration of 10% (m/v) in PBS. For the
hybrid hydrogels, the prepolymer solutions contained 7.5% (m/v) of Phe-PEA or Ala-PEA and
2.5% (m/v) of PEG-DMA or MCS. The photoinitiator, 2-hydroxy-4’-(2-hydroxyethoxy)-2methylpropiophenone (Irgacure 2959, Sigma-Aldrich) was added last to the solution at a
concentration of 0.15% (m/v). The prepolymer solution was then transferred to a 1 mL syringe
(Thermo Scientific, Waltham, MA, USA), and photo-crosslinked with long-wavelength
ultraviolet light (365 nm) at an intensity of 16 mW/cm2 for 4 min (2 min on each side of the
syringe).

Measurement of gel content and equilibrium water content. Gel content and equilibrium
water content (EWC) were measured in cell-free hydrogels (n = 3). After photo-crosslinking, the
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initial mass (mi) of each hydrogel was recorded and the theoretical mass (mt) of polymers
involved in crosslinking was calculated as mi x 0.1 based on 10 m/v % in the formulation. The
hydrogels were then swollen in PBS for 24 hr, and the swollen mass (ms) was recorded to
determine the EWC. Then, the hydrogels were rinsed three times successively in distilled water
for 3 hr to remove remaining non-crosslinked materials and salts from PBS. Following the rinses,
the hydrogels were frozen in liquid N2, lyophilized, and their dry masses (md) were measured.
The gel content and EWC were calculated using equations (1) and (2) respectively:
Gel content =
EWC =

!# " !!
!#

!!
!"

x 100%

(1)

x 100%

(2)

Measurement of mass swelling ratio. After the hydrogels were prepared, their masses (mi) were
recorded. The hydrogels were then swollen to equilibrium in PBS at 37 °C for 24 hr, and the
swollen mass was recorded (ms). The mass swelling ratio was calculated according to the
following equation:
Mass swelling ratio =

!# " !$
!$

x 100%

(3)

Measurement of the Young’s moduli under unconfined compression. Cylindrical samples
with diameters of ~5 mm and heights of ~10 mm (n = 3) were prepared in 1 mL syringes as
described above and equilibrated in PBS for 24 hr. Before compression testing, the dimensions of
the swollen hydrogels were accurately measured using calipers. Unconfined stress-strain
measurements were conducted using a UniVert system (CellScale, Waterloo, ON, Canada),
equipped with a 0.5 N load cell. During the measurement, the samples were immersed in a 37 °C
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PBS bath, preloaded at 0.01 N at every cycle, and compressed to a total strain of 20% at a rate of
0.6%/s. The nominal stress was calculated by dividing the applied force by the initial crosssectional area of the sample. The compressive modulus was determined from the slope of the
linear region of the stress-strain curve between 10 and 15% strain.

Human adipose-derived stromal cell isolation and culture. Adipose tissue was obtained with
informed consent from female patients undergoing elective lipo-reduction surgeries at the
University Hospital and St. Joseph’s Hospital in London, ON, Canada, with Human Research
Ethics Board approval from Western University (Protocol #105426). Within 2 hr of extraction,
the samples were transported to the lab on ice in sterile phosphate buffer saline (PBS)
supplemented with 20 mg/mL bovine serum albumin (BSA). Human ASCs were isolated within
2 hr of procurement using previously published methods [51, 52]. The cells were cultured in
proliferation medium comprised of DMEM:Ham’s F-12 medium (Wisent Bio Products,
Montreal, QC) supplemented with 10% fetal bovine serum (FBS; Wisent Bio Products) and 100
U/mL penicillin and 0.1 mg/mL streptomycin (1% pen-strep; Wisent Bio Products). Fresh
proliferation medium was provided every 2-3 days. The cells were passaged at 80% confluence
using 0.25% trypsin/0.1% EDTA (Wisent Bio Products) and re-plated in new flasks at 6,0007,000 cells/cm2. Passage 4 (P4) ASCs were used for all cell encapsulation studies, and each study
was repeated with three different donors (N = 3).

ASC encapsulation and culture within Phe-PEA/Ala-PEA based hydrogels. The polymer
solutions of Phe-PEA or Ala-PEA were prepared as described for the fabrication of the
hydrogels. ASCs at P4 were suspended in proliferation medium at a concentration of 1 x 107
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cells/mL and combined with the polymer solution for hydrogel encapsulation. The final solution
volume contained 80% polymer solution and 20% ASC suspension by volume and was then
photo-crosslinked as described above. Immediately after crosslinking, the hydrogels were cut into
25 µL volume disks, each containing ~2.5 x 105 cells, transferred into 12-well inserts (Greiner
Bio-one, Germany), and cultured in proliferation medium at 37 °C with 5% CO2. After 24 hr, the
hydrogels were transferred into serum-free adipogenic differentiation medium comprised of
DMEM:Ham’s F-12 nutrient mixture supplemented with 1% pen-strep, 33 µM biotin, 17 µM
pantothenate, 10 µg/mL transferrin, 100 nM hydrocortisone, 66 nM insulin, and 1 nM
triiodothyronine, with 0.25 mM isobutylmethylxanthine and 1 µg/mL troglitazone included for
the first 72 hr [53]. Fresh medium was provided to all samples every 2-3 days.

Cell viability. Viability of the encapsulated ASCs in the Phe-PEA and Ala-PEA hydrogels was
assessed at 24 hr after encapsulation and at 7 days after the induction of adipogenic
differentiation (n = 3 replicate scaffolds/trial, N = 3 trials with different ASC donors) using the
LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian cells (Cat. # L-3224; Life Technologies
Inc., Burlington, ON, Canada). During preparation, the hydrogels were rinsed twice in PBS
before incubation in 1X staining solution for 45 min at 37 °C. Next, the hydrogels were rinsed
two times with PBS before imaging using a Zeiss LSM 800 confocal microscope (Zeiss Canada,
Toronto, ON, Canada). The complete cross-sectional area of each hydrogel was imaged at 10X
magnification and mosaic images were generated using the Zen software (Zeiss Canada) stitching
command. A total of 5 layers, separated by 75 µm, were imaged for each hydrogel sample.
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Image J analysis software was used to quantify the number of live and dead cells in each layer in
order to calculate the average cell viability and density for each group.

Glycerol-3-phosphate dehydrogenase (GPDH) activity. Quantitative assessment of ASC
adipogenesis was conducted by measuring intracellular GPDH enzyme activity in the Phe-PEA
and Ala-PEA hydrogels at 7 days after adipogenic induction (n = 3, N = 3) using a GPDH
Enzyme Activity Measurement Kit (Kamiya Biomedical Corporation, Cat. # KT-010, Seattle,
WA, USA) following published methods [54, 55]. ASCs cultured on tissue culture polystyrene in
6-well plates in proliferation medium (non-induced) or adipogenic differentiation medium
(induced) for 7 days were included as assay controls. To normalize the GPDH activity levels, the
total cytosolic protein content for all samples was measured using the Pierce 660 Protein Assay
Kit (Thermo Scientific, Waltham, MA, USA) with an albumin standard. Total protein content
and GPDH activity were measured using a CLARIOstar® spectrophotometer (BMG Labtech,
Ortenberg, Germany).

BODIPY staining. Qualitative assessment of ASC adipogenesis was performed using BODIPY®
493/503 staining (Thermo Scientific, Waltham, MA, USA) to visualize intracellular lipid
accumulation in the ASCs encapsulated in the Phe-PEA and Ala-PEA hydrogels at 7 days after
adipogenic induction (n = 3, N = 3). The BODIPY® was reconstituted in DMSO at 1 mg/mL and
diluted in PBS by a factor of 1:500. The hydrogels were rinsed two times in PBS and then
incubated in the staining solution at 37 °C for 1 hr. Following incubation, the hydrogels were
rinsed twice in PBS before imaging with the Zeiss LSM 800 confocal microscope at 25X
magnification.
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Statistical analysis. Data are reported as the mean ± standard deviation (SD), and the statistical
analyses were performed using GraphPad Prism 6 (GraphPad Software, San Diego, CA, USA) by
two-way ANOVA with a Tukey’s post-hoc test (Figures 3, 5) or t-test (Figure 4g, 6). Differences
were considered statistically significant at p < 0.05.

Results and Discussion
Polymer synthesis and characterization. The initial objective was to synthesize water-soluble
PEAs containing crosslinkable moieties in their backbones to allow for hydrogel formation in
aqueous conditions for ASC encapsulation. Monomers 1a, 1b, and 1c (Scheme 1) were
synthesized as previously reported from L-phenylalanine or L-alanine and 1,4-butanediol or 1,8butanediol via Fischer esterification [48, 49]. The aim was to compare the effects of the different
amino acids and diols on the properties of the resulting PEA hydrogels. However, the monomer
composed of L-alanine and 1,4-butanediol could not be prepared in acceptable yield and purity
for polymerization. Diamino PEG macromonomer (2) (2000 g/mol) was prepared as described in
the supporting information via tosylation and subsequent amination of PEG diol. The role of
macromonomer 2 was to impart water-solubility to the resulting PEAs. Di-p-nitrophenyl
fumarate (3) was synthesized as previously reported [48] to provide crosslinkable moieties along
the PEA backbone for hydrogel preparation.
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Scheme 1. PEA synthesis from different monomer combinations.

The monomers were polymerized under solution polycondensation conditions in DMA at
70 ºC using NEt3 as a base to deprotonate the ammonium salts 1a-c (Scheme 1). Unlike previous
PEA syntheses under similar conditions [49], it was necessary to reduce the polymerization time
from 48 hr to 6 hr to avoid undesired crosslinking of the resulting PEAs, which resulted in
insoluble gels, presumably due to crosslinking reactions of backbone alkenes from the
fumaramide units by Michael-type additions of remaining diamine monomers such as 1 or 2 or
due to radical generation upon prolonged heating. Three different ratios of monomers 1:2 were
examined: 50:50, 40:60 and 30:70. While higher ratios of 1:2 led to water-insoluble PEAs, at
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30:70 monomers 1:2 both Phe-PEA and Ala-PEA were soluble. However, Phe-8-PEA was not
water-soluble for any of the prepared ratios.
The molar masses of the polymers were determined by SEC (Table 1). All of the PEAs had
Mn values close to 20 kg/mol and Đ values ranging from 2.5 – 3.0. The absence of unreacted
macromonomer 2 was confirmed by the absence of a peak in the SEC trace at the location
expected for 2000 g/mol PEG (Figure S9). The Đ values were higher than expected for a stepgrowth polymerization, where they should approach 2.0. This result can likely be attributed to a
small degree of crosslinking, which was not a concern as the PEAs were designed to be
incorporated in subsequent steps into a network.

Table 1. Molar mass data for the PEAs, as measured by SEC.
Polymer

Mn (kg/mol)

Mw (kg/mol)

Đ

Phe-PEA

19.9

49.2

2.46

Phe-8-PEA

20.1

56.6

2.81

Ala-PEA

18.9

56.1

2.96

1

H NMR and FT-IR spectroscopic analyses were consistent with the structures of the

proposed polymers. 1H NMR spectra had peaks at ~8.8 and 8.5 ppm corresponding to the amide NH- protons adjacent to monomers 1 and macromonomer 2 respectively (Figure 1, S5-S7). The
spectra also had peaks at ~6.8 ppm corresponding to the =CH fumaramide units along the
backbone and peaks at 3.5 ppm corresponding to PEG. The spectrum of Phe-PEA was
differentiated from that of Ala-PEA by the presence of peaks corresponding to the pendent
phenyl groups of phenylalanine from 7.3 to 7.2 ppm, and the peaks from 3.1 – 2.9 ppm due to the
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-CH2- moieties adjacent to the phenyl groups (Figure 1a). In contrast, Ala-PEA had peaks at ~1.3
ppm corresponding to the backbone octyl chain and pendent methyl groups on alanine (Figure
1b). Overall, the integrations of the peaks corresponded closely to the feed molar ratios of
monomer 1:2:3 at 0.3:0.7:1.0 (Figures S5-S7). The FT-IR spectra were also consistent with the
successful synthesis of PEAs with characteristic peaks corresponding to the amide N-H stretch at
3300 cm-1, the ester C=O stretch at 1740 cm-1, the amide C=O stretch at 1640 cm-1, and the amide
N-H bend at 1550 cm-1 (Figure S8).

Figure 1. 1H NMR spectra of a) Phe-PEA and b) Ala-PEA in DMSO-d6 (400 MHz).

Fabrication and characterization of hydrogels. After the successful synthesis of the watersoluble PEAs Phe-PEA and Ala-PEA with backbone alkenes for crosslinking, their gelation was
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investigated. Irgacure 2959 was used as a photoinitiator at a concentration of 0.15% (m/v). In
addition to formulations incorporating only the PEAs (10 % m/v) and initiator, formulations
incorporating PEG-DMA or MCS at 2.5% (m/v) (Figure 2) in addition to PEA at 7.5% (w/v)
were also investigated to tune the hydrogel properties. PEG-DMA was selected because PEG
tends to be well tolerated in vivo and has been extensively used for hydrogel formation [10, 56].
MCS was selected as it has previously been shown to provide a microenvironment that supports
the viability and adipogenic differentiation of encapsulated human ASCs [54, 55], and increased
production of soluble and cell-associated chondroitin 4-sulphate proteoglycans has also been
linked to adipogenesis in the murine 3T3-L1 preadipocyte cell line [57]. Crosslinking was
performed in syringes and was induced by irradiation with 365 nm light for 4 min (2 min per side
of syringe). These conditions were previously found to be well tolerated by ASCs when
encapsulated into MCS-based hydrogels [58].

Figure 2. Chemical structures of a) PEG-DMA and b) MCS.

To understand the effects of the different hydrogel compositions on their properties, all of
the hydrogels were characterized by the measurement of their gel content, EWC and mass
swelling ratio. Gel content is the mass percentage of material successfully incorporated into the
network, while EWC represents the swelling degree of the crosslinked network with water
relative to the dry weight of gel. For gel content, there was a common trend that all Phe-PEAbased systems had a higher gel content than the Ala-PEA-based systems (Figure 3a). However,
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the difference was only statistically significant for the systems with PEG-DMA incorporated. The
incorporation of PEG-DMA or MCS generally decreased the gel content relative to that of the
pure PEA, but again the difference was only statistically significant when comparing pure AlaPEA to Ala-PEA + PEG-DMA. The results suggest that the additives disrupted the crosslinking
to a small extent, perhaps due to phase separation with the PEA or due to poor compatibility of
the methacrylates with the fumaramides in the polymerization reaction. There were no significant
differences in the EWC across the examined hydrogels. Although the differences were not
statistically significant, the Ala-PEA hydrogels tended to swell more than the Phe-PEA
hydrogels. Higher swelling may be attributed to the trend towards lower gel content for the AlaPEA hydrogels, as lower gel content would suggest a lower density of crosslinks in the network.
However, it could also relate to the relative hydrophilicities of the PEAs. Although the alaninebased monomer 1c has a longer aliphatic diol chain than the phenylalanine monomer 1a, the
methyl side chains on alanine are much less hydrophobic than the phenyl side chains of
phenylalanine. Overall, the hydrogels with PEG-DMA and MCS incorporated tended to swell
more than those prepared from pure PEAs. This result may relate to their lower gel content, and
also to the presence of charges on MCS, which results in an influx of water through osmosis.
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Figure 3. a) Gel content of the hydrogels; b) Equilibrium water content of the hydrogels; c) Mass
swelling ratio of the hydrogels. The experiments were performed in triplicate and the data are
presented as the mean, with error bars corresponding to the SD. Data were analyzed by two-way
ANOVA with a Tukey’s post-hoc comparison of the means (p < 0.05). *denotes a statistically
significant difference between groups.

The Young’s moduli of selected hydrogels were evaluated under unconfined compression.
These efforts focused on hydrogels composed of the pure PEAs as hybrid hydrogels containing
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PEG-DMA or MCS were very brittle and tended to fracture (Figure 4a-f), making compression
testing impossible and prohibiting their inclusion in the cell encapsulation studies. Similar to their
lower gel contents, the poor mechanical properties of the hydrogels containing PEG-DMA or
MCS can likely be attributed to the disruption of crosslinking due to polymer phase separation or
incompatibilities between crosslinking moieties.

Figure 4. Representative images of the hydrogels after removal from the syringe mold: a) PhePEA, b) Phe-PEA + PEG-DMA, c) Phe-PEA + MCS, d) Ala-PEA, e) Ala-PEA + PEG-DMA and
f) Ala-PEA + MCS. Scale bar: 5 mm. Hydrogels prepared with PEG-DMA and MCS tended to
fracture. g) Comparison of the Young’s moduli of Phe-PEA and Ala-PEA measured under
unconfined compression. The experiments were performed in triplicate and the data are
presented as the mean, with error bars corresponding to the SD. Data were analyzed by a t-test (p
< 0.05). *denotes a statistically significant difference between groups.

For the pure PEAs, Phe-PEA had a modulus of 106 ± 11 kPa and Ala-PEA had a modulus
of 44 ± 13 kPa. The higher moduli for the Phe-PEA hydrogels may result from their trend
towards lower EWC and swelling relative to the Ala-PEA systems, as this would result in a
higher density of polymer in the network, leading to higher stiffness. Hydrophobic interactions
between the phenyl groups in Phe-PEA, may also contribute to higher stiffness. The moduli of
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both hydrogels were higher than that of adipose tissue, which is ~ 2-4 kPa, but in the range of
other soft tissues such as muscle, bladder, and cornea [59] and similar to previous chitosan- and
chondroitin sulfate-based hydrogels that have been shown to support the viability and adipogenic
differentiation of ASCs [54].

Cell viability. To assess the capacity of the hydrogel scaffolds to support ASCs during
encapsulation and adipogenic induction, the viability of ASCs encapsulated in the Phe-PEA and
Ala-PEA hydrogels was assessed at 24 hr post-encapsulation, as well as at 7 days after
adipogenic induction, through LIVE/DEAD® imaging analysis by confocal microscopy (Figure
5). Visualization of the cell distribution across the complete cross-section of the hydrogels
revealed that there was a more homogenous distribution of ASCs in the Ala-PEA hydrogels,
which was particularly evident at 24 hr (Figure 5a). Notably, the Phe-PEA polymer solution was
more viscous, which made mixing to combine it with the ASC suspension more challenging and
likely resulted in the observed regions that were devoid of cells.
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Figure 5. Viability analysis of ASCs encapsulated in the Phe-PEA and Ala-PEA hydrogels.
Representative images of the encapsulated ASCs at a) 24 hr after encapsulation and b) 7 days
after adipogenic induction displaying the distribution of live (green; calcein-AM+) and dead (red;
ethidium homodimer-1+) cells. Higher magnification images of the boxed regions in each
complete hydrogel cross-section (scale bar: 500 µm) are shown on the right (scale bar: 50 µm).
c) Percent viability and d) average number of viable ASCs per xy plane in the Phe-PEA and AlaPEA hydrogels. Data are presented as the mean with error bars corresponding to the standard
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deviations (n = 3 hydrogel replicates/trial, N = 3 trials with different ASC donors). Data were
analyzed by two-way ANOVA with a Tukey’s post-hoc comparison of the means. No significant
differences were observed between any of the groups.

Quantification of the staining at 24 hr post-encapsulation indicated that the ASC viability in
both the Phe-PEA and Ala-PEA hydrogels was > 75%, with no significant differences observed
between the systems (Figure 5c). These findings are similar to previous levels observed with
human ASCs encapsulated into MCS or methacrylated glycol chitosan (MGC) hydrogels via
light-initiated crosslinking [54]. Overall, the viability results at 24 hr support that the
encapsulation process was well-tolerated by the human ASCs. While not statistically significant,
lower ASC viability was observed after 7 days of culture in adipogenic differentiation medium
for both hydrogel groups. Again, these results are consistent with previous levels reported for the
ASCs encapsulated in the MCS and MGC hydrogels, where a decline in viability was observed
after 14 days of culture in adipogenic differentiation medium [54]. While favorable for inducing
growth arrest in order to stimulate ASC adipogenesis, the lack of serum within the adipogenic
differentiation medium may have contributed to the trend for declining viability over time in
culture. To try to mitigate these effects, in the future it would be interesting to explore the
incorporation of ECM components, such as decellularized adipose tissue (DAT) particles, which
were previously shown to enhance the long-term viability and adipogenic differentiation of ASCs
within the MCS and MGC hydrogels [54]. Similar to the viability results, there were no
significant differences observed in the viable cell density per plane for either of the hydrogel
groups at both time points studied (Figure 5d), indicating that differences in ASC density were
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not a confounding factor in comparing the levels of adipogenic differentiation between the two
systems [55].

Assessment of adipogenesis. The capacity of the hydrogels to support the adipogenic
differentiation of the encapsulated ASCs for potential adipose tissue engineering applications was
also assessed. Quantification of GPDH enzyme activity, which is upregulated during ASC
adipogenesis, indicated that there were no significant differences between the Phe-PEA and AlaPEA groups at 7 days post-induction of differentiation, with both groups showing enhanced
levels compared to the non-induced tissue culture controls (Figure 6a). The GPDH activity levels
observed were similar to those previously reported for the human ASCs encapsulated in the MCS
and MGC hydrogels at 7 days [54]. The enhanced GPDH activity in the induced tissue culture
controls relative to the hydrogel groups may be related to the high levels of cell-cell contact
achieved in the high-density 2-D cultures as compared to the distribution of single cells that was
observed within the hydrogels [55, 60]. Consistent with the GPDH results, BODIPY staining
revealed a qualitatively-similar and abundant number of lipid-loaded cells in both the Phe-PEA
and Ala-PEA hydrogels (Figure 6b), confirming that both systems were supportive of ASC
adipogenesis. In the future, it would be worthwhile to explore the effects of increasing the cell
density within the hydrogels, as well as extending the studies to longer timepoints, to elucidate
whether there may be subtle differences in the capacity of the two PEA formulations to promote
the adipogenic differentiation of the human ASCs that could be detected under varying culture
conditions.
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Figure 6. In vitro analysis of ASC adipogenesis within the hydrogels at 7 days post-induction of
differentiation. a) GPDH enzyme activity for ASCs encapsulated in either Phe-PEA or Ala-PEA
hydrogels. Data are presented as the mean with error bars corresponding to the standard
deviations (n = 3 hydrogel replicates/trial, N = 3 trials with different ASC donors). Dotted and
dashed lines represent the mean values for the induced (cultured in adipogenic differentiation
medium) and non-induced (cultured in proliferation medium) tissue culture control groups
respectively. The hydrogel groups were compared with a t-test and no significant differences
were observed. b) Representative images of BODIPY-stained (green) ASCs encapsulated in the
Phe-PEA and Ala-PEA hydrogels showing qualitatively similar numbers of differentiating ASCs
containing intracellular lipid droplets after 7 days of culture in adipogenic differentiation
medium. Scale bar: 50 µm
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Conclusions
New water-soluble PEAs with crosslinkable moieties in their backbones were successfully
synthesized from a phenylalanine-based monomer, alanine-based monomer, p-nitrophenyl
fumarate and a PEG diamine. The PEAs were only water soluble when a 70:30 ratio of
PEG:amino acid monomer was used and for Phe-PEA and Ala-PEA, but not Phe-8-PEA. Using
365 nm light and a photoinitiator, hydrogels were prepared from the pure PEAs (10% w/v) and
from the PEAs (7.5% w/v) with either PEG-DMA (2.5% w/v) or MCS (2.5% w/v). The Phe-PEA
hydrogels tended to exhibit higher gel content, lower EWC and less swelling than the Ala-PEA
hydrogels, though the differences were small and not statistically significant in many cases. The
incorporation of PEG-DMA or MCS tended to decrease the gel content, increase the EWC,
increase the swelling, and made the hydrogels brittle. Hydrogels composed of pure Phe-PEA and
Ala-PEA had Young’s moduli of 106 and 44 kPa respectively. Human ASCs were successfully
encapsulated within the Phe-PEA and Ala-PEA hydrogels via light-initiated crosslinking, with
viabilities higher than 75% at 24 hr. While there was a trend towards declining viability over time
in culture, the Phe-PEA and Ala-PEA hydrogels were shown to similarly support the adipogenic
differentiation of the encapsulated ASCs, with an abundant number of lipid-loaded cells observed
after only 7 days of culture in adipogenic differentiation medium. Overall, the findings support
the further investigation of these novel water-soluble PEAs as an ASC delivery platform for
applications in adipose tissue regeneration.
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